Correlation Between Australia and PYC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Australia and PYC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Australia and PYC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Australia and New and PYC Therapeutics, you can compare the effects of market volatilities on Australia and PYC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Australia with a short position of PYC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Australia and PYC Therapeutics.

Diversification Opportunities for Australia and PYC Therapeutics

0.61

Correlation Coefficient

Australia  PYC Therapeutics

Poor diversification

The 3 months correlation between Australia and PYC is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Australia and New and PYC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PYC Therapeutics and Australia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Australia and New are associated (or correlated) with PYC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PYC Therapeutics has no effect on the direction of Australia i.e., Australia and PYC Therapeutics go up and down completely randomly.

Pair Corralation between Australia and PYC Therapeutics

Assuming the 90 days trading horizon Australia is expected to generate 3.91 times less return on investment than PYC Therapeutics. But when comparing it to its historical volatility, Australia and New is 4.76 times less risky than PYC Therapeutics. It trades about 0.07 of its potential returns per unit of risk. PYC Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  64.00  in PYC Therapeutics on September 26, 2024 and sell it today you would earn a total of  76.00  from holding PYC Therapeutics or generate 118.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Australia and New  vs.  PYC Therapeutics

Australia and New

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Australia and New has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Australia is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

PYC Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Australia and PYC Therapeutics

The main advantage of trading using opposite Australia and PYC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Australia position performs unexpectedly, PYC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PYC Therapeutics will offset losses from the drop in PYC Therapeutics' long position.

The idea behind Australia and New and PYC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.